Gianluigi Reda

2.1k total citations
57 papers, 457 citations indexed

About

Gianluigi Reda is a scholar working on Genetics, Hematology and Pathology and Forensic Medicine. According to data from OpenAlex, Gianluigi Reda has authored 57 papers receiving a total of 457 indexed citations (citations by other indexed papers that have themselves been cited), including 44 papers in Genetics, 22 papers in Hematology and 19 papers in Pathology and Forensic Medicine. Recurrent topics in Gianluigi Reda's work include Chronic Lymphocytic Leukemia Research (36 papers), Lymphoma Diagnosis and Treatment (19 papers) and Immunodeficiency and Autoimmune Disorders (16 papers). Gianluigi Reda is often cited by papers focused on Chronic Lymphocytic Leukemia Research (36 papers), Lymphoma Diagnosis and Treatment (19 papers) and Immunodeficiency and Autoimmune Disorders (16 papers). Gianluigi Reda collaborates with scholars based in Italy, United States and France. Gianluigi Reda's co-authors include Agostino Cortelezzi, Wilma Barcellini, Ramona Cassin, Natascia Campostrini, Michela Corbella, Bruno Fattizzo, Domenico Girelli, Valeria Santini, Alessandro Sanna and Oliviero Olivieri and has published in prestigious journals such as Blood, PLoS ONE and Clinical Cancer Research.

In The Last Decade

Gianluigi Reda

50 papers receiving 452 citations

Peers — A (Enhanced Table)

Peers by citation overlap · career bar shows stage (early→late) cites · hero ref

Name h Career Trend Papers Cites
Gianluigi Reda Italy 11 302 179 156 136 70 57 457
J. D. Hoyer United States 12 331 1.1× 209 1.2× 137 0.9× 84 0.6× 37 0.5× 20 521
Melih Aktan Türkiye 12 162 0.5× 107 0.6× 112 0.7× 94 0.7× 39 0.6× 42 458
John P. Garton United States 10 205 0.7× 314 1.8× 93 0.6× 72 0.5× 121 1.7× 11 570
Dorthe Rønnov‐Jessen Denmark 9 159 0.5× 293 1.6× 100 0.6× 46 0.3× 59 0.8× 14 465
Yingqi Shao China 12 134 0.4× 256 1.4× 17 0.1× 197 1.4× 59 0.8× 53 492
Amie Fonder United States 8 194 0.6× 112 0.6× 110 0.7× 43 0.3× 63 0.9× 31 291
D Loukopoulos Greece 12 253 0.8× 153 0.9× 41 0.3× 50 0.4× 43 0.6× 27 366
Lidia Usnarska‐Zubkiewicz Poland 11 108 0.4× 169 0.9× 55 0.4× 65 0.5× 133 1.9× 55 352
Pierluigi Marradi Italy 12 99 0.3× 103 0.6× 71 0.5× 19 0.1× 91 1.3× 22 377
Liliane Morel-Maroger Striker United States 6 90 0.3× 72 0.4× 70 0.4× 41 0.3× 83 1.2× 9 362

Countries citing papers authored by Gianluigi Reda

Since Specialization
Citations

This map shows the geographic impact of Gianluigi Reda's research. It shows the number of citations coming from papers published by authors working in each country. You can also color the map by specialization and compare the number of citations received by Gianluigi Reda with the expected number of citations based on a country's size and research output (numbers larger than one mean the country cites Gianluigi Reda more than expected).

Fields of papers citing papers by Gianluigi Reda

Since Specialization
Physical SciencesHealth SciencesLife SciencesSocial Sciences

This network shows the impact of papers produced by Gianluigi Reda. Nodes represent research fields, and links connect fields that are likely to share authors. Colored nodes show fields that tend to cite the papers produced by Gianluigi Reda. The network helps show where Gianluigi Reda may publish in the future.

Co-authorship network of co-authors of Gianluigi Reda

This figure shows the co-authorship network connecting the top 25 collaborators of Gianluigi Reda. A scholar is included among the top collaborators of Gianluigi Reda based on the total number of citations received by their joint publications. Widths of edges represent the number of papers authors have co-authored together. Node borders signify the number of papers an author published with Gianluigi Reda. Gianluigi Reda is excluded from the visualization to improve readability, since they are connected to all nodes in the network.

All Works

20 of 20 papers shown
1.
2.
Barone, Angelica, et al.. (2023). Predictors of ibrutinib‐associated atrial fibrillation: 5‐year follow‐up of a prospective study. Hematological Oncology. 41(3). 363–370. 7 indexed citations
3.
Boggio, Francesca, Giorgio Alberto Croci, Ramona Cassin, et al.. (2021). Lymphocytic Infiltrate and p53 Protein Expression as Predictive Markers of Response and Outcome in Myelodysplastic Syndromes Treated with Azacitidine. Journal of Clinical Medicine. 10(21). 4809–4809.
4.
Puzzolo, Maria Cristina, Ilaria Del Giudice, Nadia Peragine, et al.. (2021). TH2/TH1 Shift Under Ibrutinib Treatment in Chronic Lymphocytic Leukemia. Frontiers in Oncology. 11. 637186–637186. 18 indexed citations
5.
Capecchi, Marco, Juri Alessandro Giannotta, Gianluigi Reda, et al.. (2021). Off-Label Use of Thrombopoietin Receptor Agonists: Case Series and Review of the Literature. Frontiers in Oncology. 11. 680411–680411. 5 indexed citations
6.
Cassaro, Adriana, Giovanni Grillo, Marco Notaro, et al.. (2021). FZD6 triggers Wnt–signalling driven by WNT10B IVS1 expression and highlights new targets in T‐cell acute lymphoblastic leukemia. Hematological Oncology. 39(3). 364–379. 7 indexed citations
7.
Farina, Lucia, Francesco Barretta, Lydia Scarfò, et al.. (2020). Refractory and 17p-deleted chronic lymphocytic leukemia: improving survival with pathway inhibitors and allogeneic stem cell transplantation. Biology of Blood and Marrow Transplantation. 26(10). e256–e262. 3 indexed citations
8.
Reda, Gianluigi, et al.. (2018). Predictors of atrial fibrillation in ibrutinib-treated CLL patients: a prospective study. Journal of Hematology & Oncology. 11(1). 79–79. 33 indexed citations
9.
Reda, Gianluigi, Marta Riva, Bruno Fattizzo, et al.. (2018). Bone Marrow Fibrosis and Early Hematological Response as Predictors of Poor Outcome in Azacitidine Treated High Risk-Patients With Myelodysplastic Syndromes or Acute Myeloid Leukemia. Seminars in Hematology. 55(4). 202–208. 5 indexed citations
10.
Autore, Francesco, Paolo Strati, Idanna Innocenti, et al.. (2016). LDH Levels Predict Progression-Free Survival in Treatment-NaÏVe Patients with Trisomy 12 Chronic Lymphocytic Leukemia. Blood. 128(22). 3211–3211. 2 indexed citations
11.
Barcellini, Wilma, Francesca Guia Imperiali, Anna Zaninoni, et al.. (2013). Toll-like receptor 4 and 9 expression in B-chronic lymphocytic leukemia: relationship with infections, autoimmunity and disease progression. Leukemia & lymphoma. 55(8). 1768–1773. 17 indexed citations
12.
Visco, Carlo, Francesco Maura, Giacomo Tuana, et al.. (2012). Immune Thrombocytopenia in Patients with Chronic Lymphocytic Leukemia Is Associated with Stereotyped B-cell Receptors. Clinical Cancer Research. 18(7). 1870–1878. 20 indexed citations
13.
Reda, Gianluigi, Francesco Maura, Giuseppe Gritti, et al.. (2012). Low‐dose alemtuzumab‐associated immune thrombocytopenia in chronic lymphocytic leukemia. American Journal of Hematology. 87(9). 936–937. 14 indexed citations
14.
Castelli, Roberto, Giuseppe Gritti, Antonino Cannavò, et al.. (2012). Successful management with intravenous immunoglobulins in alemtuzumab-induced acute inflammatory demyelinating neuropathy: clinical report of three patients. Immunopharmacology and Immunotoxicology. 34(4). 717–720. 4 indexed citations
15.
Gritti, Giuseppe, Gianluigi Reda, Francesco Maura, et al.. (2011). Low dose alemtuzumab in patients with fludarabine-refractory chronic lymphocytic leukemia. Leukemia & lymphoma. 53(3). 424–429. 10 indexed citations
16.
Cortelezzi, Agostino, Giuseppe Gritti, Luca Laurenti, et al.. (2011). An Italian retrospective study on the routine clinical use of low‐dose alemtuzumab in relapsed/refractory chronic lymphocytic leukaemia patients. British Journal of Haematology. 156(4). 481–489. 16 indexed citations
17.
Santini, Valeria, Domenico Girelli, Alessandro Sanna, et al.. (2011). Hepcidin Levels and Their Determinants in Different Types of Myelodysplastic Syndromes. PLoS ONE. 6(8). e23109–e23109. 107 indexed citations
18.
Iurlo, Alessandra, et al.. (2007). Conjunctival hemorrhagic events associated with imatinib mesylate. International Journal of Hematology. 86(5). 390–393. 19 indexed citations
19.
Cortelezzi, Agostino, Umberto Gianelli, Barbara Sarina, et al.. (2006). Low dose campath 1-H is highly effective and safe in advanced chronic CLL. Haematologica. 91. 76–76. 1 indexed citations
20.
Lauro, Roberto Di, et al.. (1978). [Biochemical profile of essential arterial hypertension. Indications for a targeted therapy: experience with propranolol].. Munich Personal RePEc Archive (Ludwig Maximilian University of Munich). 85(1). 19–25. 3 indexed citations

Rankless uses publication and citation data sourced from OpenAlex, an open and comprehensive bibliographic database. While OpenAlex provides broad and valuable coverage of the global research landscape, it—like all bibliographic datasets—has inherent limitations. These include incomplete records, variations in author disambiguation, differences in journal indexing, and delays in data updates. As a result, some metrics and network relationships displayed in Rankless may not fully capture the entirety of a scholar's output or impact.

Explore authors with similar magnitude of impact

Breakdown of academic impact, for papers by J. D. Hoyer Breakdown of academic impact, for papers by Melih Aktan Breakdown of academic impact, for papers by John P. Garton Breakdown of academic impact, for papers by Dorthe Rønnov‐Jessen Breakdown of academic impact, for papers by Yingqi Shao Breakdown of academic impact, for papers by Amie Fonder Breakdown of academic impact, for papers by D Loukopoulos Breakdown of academic impact, for papers by Lidia Usnarska‐Zubkiewicz Breakdown of academic impact, for papers by Pierluigi Marradi Breakdown of academic impact, for papers by Liliane Morel-Maroger Striker
Rankless by CCL
2026